Financial results - PROVET PHARM SRL

Financial Summary - Provet Pharm Srl
Unique identification code: 15191081
Registration number: J18/65/2003
Nace: 7500
Sales - Ron
206.067
Net Profit - Ron
525
Employees
3
Open Account
Company Provet Pharm Srl with Fiscal Code 15191081 recorded a turnover of 2024 of 206.067, with a net profit of 525 and having an average number of employees of 3. The company operates in the field of Activităţi veterinare having the NACE code 7500.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Provet Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 19.315 17.245 14.575 27.345 89.358 98.040 137.393 219.433 254.441 206.067
Total Income - EUR 19.315 25.159 22.676 48.835 89.359 98.613 142.302 219.442 257.127 210.173
Total Expenses - EUR 20.374 24.163 20.557 42.494 81.884 77.982 113.316 187.838 226.312 204.428
Gross Profit/Loss - EUR -1.059 996 2.118 6.341 7.475 20.631 28.986 31.605 30.816 5.745
Net Profit/Loss - EUR -1.638 824 260 5.852 6.582 19.683 28.016 29.147 28.244 525
Employees 2 2 2 3 3 5 4 3 2 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -18.6%, from 254.441 euro in the year 2023, to 206.067 euro in 2024. The Net Profit decreased by -27.561 euro, from 28.244 euro in 2023, to 525 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Provet Pharm Srl

Rating financiar

Financial Rating -
PROVET PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Provet Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Provet Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Provet Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Provet Pharm Srl - CUI 15191081

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 67.750 66.577 139.635 173.542 164.992 157.162 215.166 199.742 196.112 150.678
Current Assets 33.152 22.507 11.861 16.108 10.137 26.523 58.876 50.219 48.454 73.346
Inventories 1.592 477 87 513 8 123 4.803 9.717 7.277 25.996
Receivables 9.924 10.682 10.909 10.190 9.055 10.622 19.551 21.615 34.651 28.379
Cash 21.637 11.348 865 5.406 1.075 15.777 34.522 18.887 6.526 18.972
Shareholders Funds 103.019 80.524 71.322 75.865 80.977 113.140 124.745 154.279 182.055 181.563
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 27.907 45.179 115.420 128.353 94.152 84.560 149.297 95.682 62.512 42.461
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7500 - 7500"
CAEN Financial Year 7500
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 73.346 euro in 2024 which includes Inventories of 25.996 euro, Receivables of 28.379 euro and cash availability of 18.972 euro.
The company's Equity was valued at 181.563 euro, while total Liabilities amounted to 42.461 euro. Equity increased by 525 euro, from 182.055 euro in 2023, to 181.563 in 2024.

Risk Reports Prices

Reviews - Provet Pharm Srl

Comments - Provet Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.